These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27866277)

  • 61. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.
    Toonkel RL; Hare JM; Matthay MA; Glassberg MK
    Am J Respir Crit Care Med; 2013 Jul; 188(2):133-40. PubMed ID: 23306542
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lung cancer in patients with idiopathic pulmonary fibrosis.
    Karampitsakos T; Tzilas V; Tringidou R; Steiropoulos P; Aidinis V; Papiris SA; Bouros D; Tzouvelekis A
    Pulm Pharmacol Ther; 2017 Aug; 45():1-10. PubMed ID: 28377145
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Idiopathic pulmonary fibrosis: The current state of the problem].
    Shmelev EI
    Ter Arkh; 2016; 88(12):103-108. PubMed ID: 28635884
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
    Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
    Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Patient expectations and experiences in idiopathic pulmonary fibrosis: implications of patient surveys for improved care.
    Belkin A; Swigris JJ
    Expert Rev Respir Med; 2014 Apr; 8(2):173-8. PubMed ID: 24450476
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis.
    Iwata T; Yoshida S; Nagato K; Nakajima T; Suzuki H; Tagawa T; Mizobuchi T; Ota S; Nakatani Y; Yoshino I
    Surg Today; 2015 Oct; 45(10):1263-70. PubMed ID: 25412984
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sleep and breathing in idiopathic pulmonary fibrosis.
    Rasche K; Orth M
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():13-4. PubMed ID: 20134032
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The impact of lung cancer on survival of idiopathic pulmonary fibrosis.
    Tomassetti S; Gurioli C; Ryu JH; Decker PA; Ravaglia C; Tantalocco P; Buccioli M; Piciucchi S; Sverzellati N; Dubini A; Gavelli G; Chilosi M; Poletti V
    Chest; 2015 Jan; 147(1):157-164. PubMed ID: 25166895
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.
    Birring SS; Wijsenbeek MS; Agrawal S; van den Berg JWK; Stone H; Maher TM; Tutuncu A; Morice AH
    Lancet Respir Med; 2017 Oct; 5(10):806-815. PubMed ID: 28923239
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IPF, comorbidities and management implications.
    Vancheri C; Cottin V; Kreuter M; Hilberg O
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():17-23. PubMed ID: 26237439
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
    Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
    BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.
    Yount SE; Beaumont JL; Chen SY; Kaiser K; Wortman K; Van Brunt DL; Swigris J; Cella D
    Lung; 2016 Apr; 194(2):227-34. PubMed ID: 26861885
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
    Klingsberg RC; Mutsaers SE; Lasky JA
    Respirology; 2010 Jan; 15(1):19-31. PubMed ID: 20199632
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Emerging therapeutic interventions for idiopathic pulmonary fibrosis.
    Chakraborty S; Chopra P; Ambi SV; Dastidar SG; Ray A
    Expert Opin Investig Drugs; 2014 Jul; 23(7):893-910. PubMed ID: 24766571
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.
    Tan J; Tedrow JR; Dutta JA; Juan-Guardela B; Nouraie M; Chu Y; Trejo Bittar H; Ramani K; Biswas PS; Veraldi KL; Kaminski N; Zhang Y; Kass DJ
    Am J Respir Crit Care Med; 2016 Dec; 194(11):1392-1402. PubMed ID: 27310652
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Single- vs double-lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis since the implementation of lung allocation based on medical need.
    Schaffer JM; Singh SK; Reitz BA; Zamanian RT; Mallidi HR
    JAMA; 2015 Mar; 313(9):936-48. PubMed ID: 25734735
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gastroesophageal reflux disease and patterns of reflux in patients with idiopathic pulmonary fibrosis using hypopharyngeal multichannel intraluminal impedance.
    Hoppo T; Komatsu Y; Jobe BA
    Dis Esophagus; 2014 Aug; 27(6):530-7. PubMed ID: 23107023
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group.
    Sköld CM; Bendstrup E; Myllärniemi M; Gudmundsson G; Sjåheim T; Hilberg O; Altraja A; Kaarteenaho R; Ferrara G
    J Intern Med; 2017 Feb; 281(2):149-166. PubMed ID: 27862475
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pulmonary hypertension and idiopathic pulmonary fibrosis: a dastardly duo.
    Smith JS; Gorbett D; Mueller J; Perez R; Daniels CJ
    Am J Med Sci; 2013 Sep; 346(3):221-5. PubMed ID: 23313949
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
    Kreuter M; Spagnolo P; Wuyts W; Renzoni E; Koschel D; Bonella F; Maher TM; Kolb M; Weycker D; Kirchgässler KU; Costabel U
    Respiration; 2017; 93(6):415-423. PubMed ID: 28399537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.